News | Page 4 | Pascal Biosciences

VANCOUVER, BRITISH COLUMBIA, October 5, 2016 -- bioMmune Technologies Inc. (TSX.V: IMU) (the “Company”) is pleased to announce that pursuant to the Company’s Incentive Stock Option Plan (the “Plan”), it has granted incentive stock options to directors and officers of the Company…

20Sep 2016

Biommune Appoints Thomas Gadek, PhD To Board of Directors

Sep 20, 2016
Press Releases

Vancouver, British Columbia, September 20, 2016 -– bioMmune Technologies Inc. (“bioMmune” or the “Company”) (TSX.V: IMU), a drug discovery and development biotechnology company, today announced the appointment of Dr. Thomas R. Gadek to its Board of Directors. “Tom’s demonstrated success…